Tuesday, December 10, 2013
Diabetic Drugs Cause Cardiovascular Disease?
In 2011, the FDA slammed restrictions on the diabetic drug, rosiglitazone, because it apparently increased the risk of vascular problems. Most diabetic complications are vascular. Other new diabetic drugs also had suspicious results. Now the FDA is saying there isn’t enough evidence to say they are safe or dangerous. A much better choice would be IV chelation therapy. The TACT study showed a 40% decrease in cardiac events in patients with diabetes and a history of a heart attack when they took chelation for only a year and a half. See Hunting for cardiovascular signals from diabetic drugs in Family Practice News, 11/1/13, p. 1, 17. and Google TACT.